
Bioorganic and Medicinal Chemistry Letters p. 2579 - 2584 (1997)
Update date:2022-08-05
Topics:
Diouf
Carato
Depreux
Bonte
Caignard
Guardiola-Lemaitre
Rettori
Belzung
Lesieur, Daniel
A series of new benzothiazolin-2-one, benzoxazolin-2-one and benzoxazin-3-one derivatives were synthesized and their binding profile at 5-HT(1A) 5-HT(2A), 5-HT(2C) as well as D2 and α1 receptors was determined. All studied compounds displayed high to moderate affinity for both 5-HT(1A) and 5-HT(2A) receptor subtypes. Among these, one compound (29) emerged since it exhibited potent antagonist activities at 5-HT(1A), 5-HT(2A), D2 and α1 central receptors and showed anxiolytic and antipanic-like effects in mice. 29 is currently undergoing preclinical evaluation.
View MoreShanghai better-in Medical Technology Co.,LTD.
Contact:+86-21-38921049
Address:Lane 720 zhangjianggaoke cailun road, Pudong, Shanghai, room 513
Changzhou Ruiping Chemical Co., Ltd
website:http://www.wishchem.com
Contact:+86-519-82324280
Address:No.288-1 Huacheng Road, Jintan
Yancheng Creator Chemical Co., Ltd
Contact:0086-515-88710008 88710068 88710858 88710868
Address:No.21 Renming Road, Longgang Town, Yandu County,Yancheng City
ANHUI CHEM-BRIGHT BIOENGINEERING CO.,LTD
Contact:86-561-4080321
Address:No.8 Lieshan Industrial Zone of Huaibei
Shanghai Sunway Pharmaceutical Technology Co.,Ltd.
Contact:+86-21-5161 3915
Address:Shanghai YangPu
Doi:10.1021/ja00267a033
(1986)Doi:10.1081/NCN-200061832
(2005)Doi:10.1021/op7000707
(2007)Doi:10.1039/b602937j
(2006)Doi:10.1016/S0040-4039(98)02514-3
(1999)Doi:10.1021/jo800769m
(2008)